Skip to search formSkip to main contentSkip to account menu

NC100100

National Institutes of Health

Related topics

Related topics

1 relation
Sonazoid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Computer-aided diagnosis of focal liver lesions by use of physicians' subjective classification of echogenic patterns in baseline and contrast-enhanced ultrasonography.
Highly Cited
2003
Highly Cited
2003
Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model.
The liver contrast effects of Sonazoid in two ultrasonographic imaging modes, gray-scale conventional and harmonic, were examined… 
Highly Cited
2002
Highly Cited
2002
Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase.
PURPOSE To compare conventional ultrasonography (US) and magnetic resonance (MR) imaging with contrast agent-enhanced US for… 
2002
2002
Harmonic Imaging of the Brain Parenchyma in a Dog Model Following NC100100 (Sonazoid™) Bolus Injection
Background and Purpose. NC100100 (Sonazoid™) is a new perfluorocarbon‐based ultrasound contrast agent (UCA) that has not been… 
2001
2001
Determination of perfluorobutane in rat blood by automatic headspace capillary gas chromatography and selected ion monitoring mass spectrometry.
2001
2001
Enhanced visualisation of the normal prostate blood flow in young healthy volunteers using a new ultrasound contrast agent.
PURPOSE To evaluate the sonographic appearance of normal prostate vascularity before and after injection of a new ultrasound… 
Highly Cited
2000
Highly Cited
2000
Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of…
BACKGROUND This study investigated whether the extent of perfusion defect determined by intravenous myocardial contrast… 
2000
2000
Gray scale second harmonic imaging of acoustic emission signals improves detection of liver tumors in rabbits.
This study evaluates a new reticuloendothelium specific sonographic contrast agent NC100100 (Sonazoid) for detection of liver VX… 
2000
2000
Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent.
RATIONALE AND OBJECTIVES To evaluate the sonographic appearance of normal prostate vascularity in dogs before and after injection… 
1999
1999
Safety of the transpulmonary ultrasound contrast agent NC100100: a clinical and haemodynamic evaluation in patients with suspected or proved coronary artery disease
OBJECTIVE To evaluate the clinical and haemodynamic safety of NC100100, a new transpulmonary ultrasound contrast agent intended… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)